Insider Trading Activity For Rosetta Genomics Ltd. (NASDAQ:ROSG)
Healthcare Master Fund Sabby , Major Shareholder of Rosetta Genomics Ltd. (NASDAQ:ROSG) reportedly Bought 119,761 shares of the company’s stock at an average price of 0.42 for a total transaction amount of $50,299.62 SEC Form
Insider Trading History For Rosetta Genomics Ltd. (NASDAQ:ROSG)
Analyst Ratings History For Rosetta Genomics Ltd. (NASDAQ:ROSG)
- On 6/13/2016 Cantor Fitzgerald Reiterated Rating Buy with a price target of $0.94 to $0.82
- On 1/6/2017 Aegis Reiterated Rating Buy with a price target of $3.50
- On 12/18/2017 Barrington Research Downgraded rating Outperform to Market Perform
Recent Trading Activity for Rosetta Genomics Ltd. (NASDAQ:ROSG)
Shares of Rosetta Genomics Ltd. closed the previous trading session at 0.43 up +0.01 1.38% with 0.42010000348091125 shares trading hands.